Autologous Is Superior to Allogeneic Hematopoietic Cell Transplantation for Acute Promyelocytic Leukemia in Second Complete Remission
Open Access
- 31 March 2014
- journal article
- research article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 20 (7), 1021-1025
- https://doi.org/10.1016/j.bbmt.2014.03.025
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute (5U10HL069294)
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases (HHSH250201200016C)
- Health Resources and Services Administration
- Office of Naval Research (N00014-12-1-0142, N00014-13-1-0039)
This publication has 14 references indexed in Scilit:
- Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemiaBlood, 2013
- Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?Leukemia Research, 2011
- Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow TransplantationBone Marrow Transplantation, 2007
- Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemiaBlood, 2006
- Cancer stem cells: lessons from leukemiaTrends in Cell Biology, 2005
- Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: long-term follow-up in acute promyelocytic leukemiaBlood, 2001
- Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignanciesBlood Reviews, 2001
- The role of bone marrow transplantation in acute promyelocytic leukemiaBone Marrow Transplantation, 2001
- Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic TrioxideThe New England Journal of Medicine, 1998
- Prolonged molecular remission after PML/RARα-positive autologous peripheral blood stem cell transplantation in acute promyelocytic leukemia: is relevant pretransplant minimal residual disease in the graft?Leukemia, 1998